Trials / Terminated
TerminatedNCT01345968
Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery
Preoperative Intravenous Ferric Carboxymaltose (Ferinject) in Patients With Orthopedic Surgery and High Risk of Blood Loss
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- University Hospital Muenster · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to evaluate the safety and efficacy of preoperative intravenous ferric carboxymaltose in patients with anemia undergoing hip or knee replacement
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ferinject 50 mg/ml | iv administration of max. 50 ml (Dilution: 20 ml in 30 ml NaCl 0.9%) in 30 minutes |
| DRUG | NaCl 0.9% | iv administration of max. 50 ml in 30 minutes |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2013-01-01
- Completion
- 2013-02-01
- First posted
- 2011-05-02
- Last updated
- 2013-08-09
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01345968. Inclusion in this directory is not an endorsement.